Novo Nordisk
NVO
#78
Rank
โ‚ฌ182.65 B
Marketcap
41,11ย โ‚ฌ
Share price
-0.27%
Change (1 day)
-59.37%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) Fails to deliver data

Key failure to deliver metrics for Novo Nordisk:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novo Nordisk (NVO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013

Volume in USD (price x number of shares), data since 2013

Novo Nordisk (NVO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ0.35 B43.62%
2024โ‚ฌ0.24 B179.42%
2023โ‚ฌ88.71 M-11.66%
2022โ‚ฌ0.10 B125.23%
2021โ‚ฌ44.58 M70.14%
2020โ‚ฌ26.2 M-57.24%
2019โ‚ฌ61.28 M-22.47%
2018โ‚ฌ79.04 M3.14%
2017โ‚ฌ76.63 M5.66%
2016โ‚ฌ72.53 M-28.24%
2015โ‚ฌ0.10 B-51.63%
2014โ‚ฌ0.20 B598.64%
2013โ‚ฌ29.9 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
โ‚ฌ24.63 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ0.21 Bโ‚ฌ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.09 Mโ‚ฌ0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ4.1 Mโ‚ฌ62.72 M๐Ÿ‡ซ๐Ÿ‡ท France